Clinical and pathological analysis of companion diagnostic testing of microsatellite instability-high for pembrolizumab in gynaecologic malignancy.
Takashi TakedaKosuke TsujiYusuke KobayashiKouji BannoDaisuke AokiPublished in: Japanese journal of clinical oncology (2021)
Microsatellite instability-high was less commonly detected as a companion diagnosis for pembrolizumab in unselected gynaecologic patients. Genetic counselling should be always provided along with treatment selection.